ENDEAVORRIDE(エンデバーライド) Android
ENDEAVORRIDE(エンデバーライド) is #121 in Medical Free on Google Play in Japan and charting in 1 of 15 countries we track.
Updated 27 Sep 2026 · rankings refresh through the day
DeveloperShionogi & Co., Ltd.
CategoryMedical
PriceFree
Released–
Installs1k+
Rating–
Updated–
Content ratingEveryone
Best rank now
#121
Measured
ENDEAVORRIDE(エンデバーライド) on Google Play
App details
App ID
com.shionogi.endeavorride
Publisher
Shionogi & Co., Ltd.
Content rating
Everyone
ENDEAVORRIDE(エンデバーライド) downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Google Play shows an exact lifetime install count; downloads per day are its daily change (measured). When Play hasn't refreshed the count, they come from new ratings and Top Free chart positions. Confidence is the chance the real number is within half to double ours.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Where it ranks on Google Play
Every top 200 chart it appears in across 15 countries.
| Country | Charts | Rank |
|---|---|---|
| MedicalFree | #121 |
Apps near ENDEAVORRIDE(エンデバーライド) on the chart
Medical Free, around #121.
About ENDEAVORRIDE(エンデバーライド)
This application is installed and used on the smartphone, tablet, or other mobile device of the patient child or their guardian.
■ Precautions
・This application is a medical device program (regulated medical device) intended to assist in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in childhood.
・This application can be used under the guidance and prescription of a physician.
・Please read the instruction manual and electronic accompanying documents and use the application correctly according to the physician's instructions.
・If you notice any adverse health effects or changes in symptoms after using this application, please consult a physician.
■ How to Use
1. Preparation
・Install the application on a general-purpose mobile device.
・Authentication using the activation code provided by the medical institution is required upon first launch of the application, followed by personal authentication.
・Follow the navigation and understand the operating instructions and precautions displayed on the screen.
2. Operation
・Launch the application installed on the mobile device.
・If necessary, check the operating instructions and precautions displayed within the application.
・Start treatment using the application. • During treatment, continue steering and tapping operations using the device (performing dual tasks). The difficulty level of the tasks will be automatically adjusted by the app.
• After all the treatments scheduled for the day are completed, close the app.
3. End
■ Refer to the electronic package insert for usage environment.
Medical device manufacturing and sales approval number: 30700BZX00033000
Generic name: Attention Deficit Hyperactivity Disorder Treatment Support Program Medical device classification: Class II medical device
Product code: 14987087043270
Product name: ENDEAVORRIDE
Manufacturer and distributor:
Name: Shionogi & Co., Ltd.
Address: 3-1-8 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
Distributor:
Name: Shionogi & Co., Ltd.
Address: 3-1-8 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
Phone number: 06-6202-2161
Sales office location:
Name: Shionogi & Co., Ltd. Global Headquarters
Address: Ofukamachi, Kita-ku, Osaka City, Osaka Prefecture 5-54 Grand Green Osaka South Building Park Tower, 24th, 25th, and 26th Floors
Notification Number: No. 25P00179
Electronic Attachment: https://wellness.shionogi.co.jp/psychosis-neurosis/developmental-disability/endeavorride/product/packageinsert.html
■License
The fonts displayed in the app are licensed from Morisawa & Co., Ltd.
■ Precautions
・This application is a medical device program (regulated medical device) intended to assist in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in childhood.
・This application can be used under the guidance and prescription of a physician.
・Please read the instruction manual and electronic accompanying documents and use the application correctly according to the physician's instructions.
・If you notice any adverse health effects or changes in symptoms after using this application, please consult a physician.
■ How to Use
1. Preparation
・Install the application on a general-purpose mobile device.
・Authentication using the activation code provided by the medical institution is required upon first launch of the application, followed by personal authentication.
・Follow the navigation and understand the operating instructions and precautions displayed on the screen.
2. Operation
・Launch the application installed on the mobile device.
・If necessary, check the operating instructions and precautions displayed within the application.
・Start treatment using the application. • During treatment, continue steering and tapping operations using the device (performing dual tasks). The difficulty level of the tasks will be automatically adjusted by the app.
• After all the treatments scheduled for the day are completed, close the app.
3. End
■ Refer to the electronic package insert for usage environment.
Medical device manufacturing and sales approval number: 30700BZX00033000
Generic name: Attention Deficit Hyperactivity Disorder Treatment Support Program Medical device classification: Class II medical device
Product code: 14987087043270
Product name: ENDEAVORRIDE
Manufacturer and distributor:
Name: Shionogi & Co., Ltd.
Address: 3-1-8 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
Distributor:
Name: Shionogi & Co., Ltd.
Address: 3-1-8 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
Phone number: 06-6202-2161
Sales office location:
Name: Shionogi & Co., Ltd. Global Headquarters
Address: Ofukamachi, Kita-ku, Osaka City, Osaka Prefecture 5-54 Grand Green Osaka South Building Park Tower, 24th, 25th, and 26th Floors
Notification Number: No. 25P00179
Electronic Attachment: https://wellness.shionogi.co.jp/psychosis-neurosis/developmental-disability/endeavorride/product/packageinsert.html
■License
The fonts displayed in the app are licensed from Morisawa & Co., Ltd.